Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 16, 2023International ImmunopharmacologyOpen Access

Indoleamine 2,3-dioxygenase 1 in circumventing checkpoint inhibitor responses: Updated

View Full Paper
Ask AI
Bookmark
Share

Authors

ACArian CharehjooJMJamal MajidpoorIran University of Medical SciencesKMKeywan MortezaeeKurdistan University of Medical Sciences

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Charehjoo et al. (2023) studied this question.

synapsesocial.com/papers/6a797df1756812e39589177fhttps://doi.org/10.1016/j.intimp.2023.110032
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy2021 · 86 citations
  2. 2IDO inhibitor synergized with radiotherapy to delay tumor growth by reversing T cell exhaustion2019 · 41 citations
  3. 3CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs2014 · 241 citations
  4. 4Immune-regulated IDO1-dependent tryptophan metabolism is source of one-carbon units for pancreatic cancer and stellate cells2021 · 117 citations